Goldman Sachs’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-170,000
| Closed | -$9.58M | – | 6438 |
|
|
2020
Q4 | $9.58M | Sell |
170,000
-88,700
| -34% | -$4.36M | ﹤0.01% | 2507 |
|
|
2020
Q3 | $12.6M | Buy |
258,700
+77,000
| +42% | +$4.15M | ﹤0.01% | 2120 |
|
|
2020
Q2 | $10.1M | Buy |
181,700
+106,600
| +142% | +$6.17M | ﹤0.01% | 2266 |
|
|
2020
Q1 | $3.81M | Sell |
75,100
-59,600
| -44% | -$4M | ﹤0.01% | 2858 |
|
|
2019
Q4 | $10.4M | Buy |
+134,700
| New | +$9.51M | ﹤0.01% | 2401 |
|
|
2019
Q3 | – | Sell |
-56,600
| Closed | -$3.31M | – | 5441 |
|
|
2019
Q2 | $3.31M | Sell |
56,600
-38,400
| -40% | -$2.27M | ﹤0.01% | 3165 |
|
|
2019
Q1 | $5.39M | Buy |
+95,000
| New | +$5.05M | ﹤0.01% | 2912 |
|
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$1.56M | – | 5847 |
|
|
2018
Q2 | $1.56M | Sell |
30,000
-15,900
| -35% | -$833K | ﹤0.01% | 3783 |
|
|
2018
Q1 | $2.4M | Sell |
45,900
-4,100
| -8% | -$208K | ﹤0.01% | 3468 |
|
|
2017
Q4 | $2.92M | Sell |
50,000
-42,700
| -46% | -$2.42M | ﹤0.01% | 3473 |
|
|
2017
Q3 | $5.14M | Sell |
92,700
-150,800
| -62% | -$9.98M | ﹤0.01% | 3104 |
|
|
2017
Q2 | $18.7M | Sell |
243,500
-12,200
| -5% | -$912K | ﹤0.01% | 1985 |
|
|
2017
Q1 | $19.1M | Buy |
+255,700
| New | +$18.6M | 0.01% | 1915 |
|
|
2015
Q3 | – | Sell |
-49,500
| Closed | -$2.35M | – | 7541 |
|
|
2015
Q2 | $2.35M | Buy |
+49,500
| New | +$2.31M | ﹤0.01% | 3679 |
|
|
2013
Q4 | – | Sell |
-20,000
| Closed | -$490K | – | 6830 |
|
|
2013
Q3 | $490K | Buy |
+20,000
| New | +$492K | ﹤0.01% | 5165 |
|
Other funds holding NUVA
Goldman Sachs's NUVA Position: Q3 2023 in Review
Goldman Sachs sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 961,190 shares — an estimated $40M sold.
Goldman Sachs first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $166M in Q2 2017. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Goldman Sachs reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Goldman Sachs sold 961,190 NuVasive, Inc. shares in Q3 2023, an estimated $40M.
- Goldman Sachs first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- Goldman Sachs's NuVasive, Inc. position peaked at $166M in Q2 2017.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.